Benjamin Hickey - 03 Jan 2022 Form 4 Insider Report for Surface Oncology, Inc.

Role
Director
Signature
Jessica Fees, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
05 Jan 2022, 17:00:16 UTC
Previous filing
16 Dec 2021
Next filing
07 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SURF Stock Option (Right to Buy) Award $0 +24,000 $0.000000 24,000 03 Jan 2022 Common Stock 24,000 $5.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest in 36 equal monthly installments following December 10, 2021, so long as the grantee remains a director or other service provider of the Company on such dates.